Image
Published: Aug 24, 2025 | DOI: 10.24911/ejmcr.9-2267
Triple antithrombotic therapy in absence of atrial fibrillation in ACS with high thrombus burden.
Authors:
Antonios Samaras
, Thrasivoulos Konstantinou
, Ioannis Vogiatzis
,
Article Info
Authors
Antonios Samaras
Department of Cardiology, General Hospital of Veroia, Veroia, Greece
Thrasivoulos Konstantinou
Department of Cardiology, General Hospital of Veroia, Veroia, Greece
Publication History
Received: June 20, 2025
Accepted: July 23, 2025
Published: August 24, 2025
Abstract
Patients with atrial fibrillation and ACS need triple antithrombotic therapy (double antiplatelet plus anticoagulant).
In cases of ACS where a high thrombus burden exists, even in the absence of atrial fibrillation, triple antithrombotic therapy (double antiplatelet plus anticoagulant) is essential.
Keywords: PCI, ACS, Triple antithrombotic therapy, Thrombus burden, Thrombus aspiration, IVUS, Deferred stenting